Ginwa Enterprise Group Inc. logo

Ginwa Enterprise Group Inc. (600080)

Market Closed
11 Aug, 06:57
SSE SSE
¥
4. 96
0
0%
¥
2.9B Market Cap
- P/E Ratio
0.36% Div Yield
1.61M Volume
- Eps
¥ 4.96
Previous Close
Add Transaction
Day Range
4.91 5.01
Year Range
4.26 9.35
Want to track 600080 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600080 closed today higher at ¥4.96, an increase of 0% from yesterday's close, completing a monthly increase of 11.4607% or ¥0.51. Over the past 12 months, 600080 stock lost -34.0426%.
600080 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.014%, based on the last three reports.
Ginwa Enterprise Group Inc. has completed 4 stock splits, with the recent split occurring on Jun 13, 2006.
The company's stock is traded on one exchange.

600080 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Ginwa Enterprise Group Inc. (600080) FAQ

What is the stock price today?

The current price is ¥4.96.

On which exchange is it traded?

Ginwa Enterprise Group Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600080.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.36%.

What is its market cap?

As of today, the market cap is 2.9B.

Has Ginwa Enterprise Group Inc. ever had a stock split?

Ginwa Enterprise Group Inc. had 4 splits and the recent split was on Jun 13, 2006.

Ginwa Enterprise Group Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Boyue Xing CEO
SSE Exchange
CNE000000QQ8 ISIN
CN Country
553 Employees
17 Jun 2021 Last Dividend
13 Jun 2006 Last Split
14 May 1997 IPO Date

Overview

Ginwa Enterprise (Group) Inc., established in 1996, is a prominent player in the Chinese pharmaceutical industry, headquartered in Xi'an, China. The company is engaged in the research, development, production, and sale of a wide range of pharmaceutical products. With a robust portfolio that addresses multiple therapeutic areas, Ginwa Enterprise (Group) Inc. is committed to improving the health and well-being of people through its innovative and effective medicinal products. The company caters to the varying needs of patients by providing pharmaceuticals in various forms, ensuring accessibility and convenience for its users.

Products and Services

The company's diverse product range encompasses treatments for numerous health conditions, designed to meet the healthcare needs of patients across different age groups and medical specialties:

  • Orthopedic Products: These include medications and treatments specifically developed for bone and joint conditions, assisting in the healing and management of orthopedic issues.
  • Immune Products: Aimed at bolstering the body's immune system, these products help in fighting infections and improving overall immune response.
  • Pediatric Products: Formulated for children, these pharmaceuticals address the unique health requirements of the pediatric population, covering a range of conditions from common illnesses to more specific pediatric issues.
  • Antibiotic Products: These are aimed at combating bacterial infections, offering a spectrum of antibiotic treatments for various infectious diseases.
  • Digestive System Products: Focused on gastrointestinal health, these products provide relief and treatment for various digestive disorders.
  • Gynecological Products: Catering specifically to women's health, these treatments address gynecological conditions and concerns.
  • Cardiovascular Products: Targeting heart and circulatory system health, these medications are designed to treat cardiovascular diseases and conditions.
  • Antipyretic and Analgesic Products: These products are intended for the relief of pain and fever, offering symptomatic relief for various conditions.
  • Antiviral Products: Created to combat viral infections, these treatments aim at inhibiting the spread of viruses and alleviating symptoms of viral diseases.

In addition to these specialized pharmaceuticals, Ginwa Enterprise (Group) Inc. offers its products in a multitude of forms, such as tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions, to suit different patient preferences and treatment requirements. The company also engages in the development and supply of chemical drugs, Chinese medicines, raw materials, and health-related products, broadening its reach in the pharmaceutical and healthcare market.

Contact Information

Address: No. 202, Keji 4th Road, Xi'an, China
Phone: 86 29 8220 0221